BE Pharmaceuticals Inc.

Manufacturer / marketing-authorisation holder

BE Pharmaceuticals Inc. — 29 products across 1 markets, 0 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

BE Pharmaceuticals Inc. — 29 productos en 1 mercados, 0 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

BE Pharmaceuticals Inc. —— 共 29 个产品,覆盖 1 个市场、0 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

29 products · 1 markets · 0 brand names

29 productos · 1 mercados · 0 marcas

29 个产品 · 1 个市场 · 0 个品牌名

Products by country

US (29 records)

Source: api.fda.gov

BrandActive ingredient(s)Form
—Fosaprepitant Dimeglumineinjection
—依诺肝素钠injection
—Phenylephrineinjection
—Dalbavancininjection
—达托霉素injection
—依诺肝素钠injection
—肝素injection
—Glycopyrrolateinjection
—Neostigmine Methylsulfateinjection
—依诺肝素钠injection
—Succinylcholineinjection
—达托霉素injection
—依诺肝素钠injection
—泮托拉唑钠injection
—肝素injection
—Carboprostinjection
—罗库溴铵injection
—Norepinephrine Bitartrateinjection
—Sodium Nitroprussideinjection
—依诺肝素钠injection
—Glycopyrrolateinjection
—Phenylephrineinjection
—Neostigmine Methylsulfateinjection
—依诺肝素钠injection
—Phenylephrineinjection
—依诺肝素钠injection
—Glycopyrrolateinjection
—Glycopyrrolateinjection
—罗库溴铵injection
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.